182
Participants
Start Date
May 28, 2002
Primary Completion Date
July 19, 2011
Study Completion Date
July 19, 2011
GSK 249553 vaccine
Intramuscular injection, 13 doses
Placebo
Intramuscular administration, 13 doses
GSK Investigational Site, Brussels
GSK Investigational Site, Edegem
GSK Investigational Site, Leuven
GSK Investigational Site, Trondheim
GSK Investigational Site, Ghent
GSK Investigational Site, Tallinn
GSK Investigational Site, Berlin
GSK Investigational Site, A Coruña
GSK Investigational Site, Marousi
GSK Investigational Site, Genoa
GSK Investigational Site, Großhansdorf
GSK Investigational Site, Rio-Patras
GSK Investigational Site, Delmenhorst
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Venezia
GSK Investigational Site, Oviedo
GSK Investigational Site, Udine
GSK Investigational Site, Pordenone
GSK Investigational Site, Tampere
GSK Investigational Site, Pessac
GSK Investigational Site, Rennes
GSK Investigational Site, Santander
GSK Investigational Site, Valencia
GSK Investigational Site, Tartu
GSK Investigational Site, Mainz
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Witten
GSK Investigational Site, Hemer
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Offenbach
GSK Investigational Site, Kaiserslautern
GSK Investigational Site, Heidelberg
GSK Investigational Site, Villingen-Schwenningen
GSK Investigational Site, Freiburg im Breisgau
GSK Investigational Site, Munich
GSK Investigational Site, Gauting
GSK Investigational Site, Ebensfeld
GSK Investigational Site, Bad Berka
GSK Investigational Site, Helsinki
GSK Investigational Site, Leipzig
GSK Investigational Site, Halle
GSK Investigational Site, Halle
GSK Investigational Site, Perugia
GSK Investigational Site, Riga
GSK Investigational Site, Rigas Rajons
GSK Investigational Site, Vilnius
GSK Investigational Site, Amsterdam
GSK Investigational Site, Oslo
GSK Investigational Site, Tuszyn
GSK Investigational Site, Warsaw
GSK Investigational Site
GSK Investigational Site, Nijmegen
GSK Investigational Site, Chęciny
GSK Investigational Site, Gdansk
GSK Investigational Site, Poznan
GSK Investigational Site, Zakopane
GSK Investigational Site, Barcelona
GSK Investigational Site, Palma de Mallorca
GSK Investigational Site, Hull
GSK Investigational Site, London
Lead Sponsor
GlaxoSmithKline
INDUSTRY